In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study-Reference-Cited by-同舟云学术

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Published:2010-07 Issue:7 Volume:28 Page:1541-1546
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Wachtell Kristian,Gerdts Eva,Palmieri Vittorio,Olsen Michael H,Nieminen Markku S,Papademetriou Vasilios,Boman Kurt,Dahlöf Björn,Aurigemma Gerard P,Rokkedal Jens E,Devereux Richard B

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference39 articles.

1. Survival of medically treated patients in the coronary artery surgery study (CASS) registry;Mock;Circulation,1982

2. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension;Devereux;Am J Cardiol,1983

3. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension [published erratum appears in J Am Coll Cardiol 1994; 24:844].;de Simone;J Am Coll Cardiol,1994

4. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension;de Simone;Circulation,1996

5. Midwall LV mechanics in rats with or without renovascular hypertension: effect of different Na+ intakes;de Simone;Am J Physiol,1996

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension and Heart Failure: From Pathophysiology to Treatment;International Journal of Molecular Sciences;2024-06-17

2. The current best drug treatment for hypertensive heart failure with preserved ejection fraction;European Journal of Internal Medicine;2024-02

3. What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence;American Journal of Hypertension;2023-08-08

4. Phenotyping the hypertensive heart;European Heart Journal;2022-07-23

5. Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study;Exploration of Medicine;2022-04-02